查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2005046

靜脈血液採集市場：依產品類型、技術、材料類型、應用和最終用戶分類－2026-2032年全球市場預測

Venous Blood Collection Market by Product Type, Technology, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈血採樣市場價值將達到 49 億美元，到 2026 年將成長至 51.4 億美元，到 2032 年將達到 69.5 億美元，複合年成長率為 5.10%。

主要市場統計數據
基準年 2025 49億美元
預計年份：2026年 51.4億美元
預測年份 2032 69.5億美元
複合年成長率 (%) 5.10%

簡要概述靜脈採血的發展趨勢，將設備創新、臨床工作流程和相關人員的採購重點連結起來。

靜脈採血是現代醫學診斷和輸血醫學的基礎環節，為急診醫學、常規檢查和複雜外科手術等臨床決策提供支援。設備設計、材料科學和自動化系統的進步正在改變營運流程和供應商的價值提案，迫使相關人員重新評估籌資策略和臨床通訊協定。本導言旨在為系統分析影響競爭格局的技術和材料創新、監管壓力以及最終用戶需求奠定基礎。

本文清楚地說明了技術進步、材料創新、監管重點和供應鏈韌性如何重塑靜脈血採集生態系統。

靜脈採血環境正經歷一場變革，這場變革是由技術、監管和營運方面的多方面因素共同推動的，它正在重新定義臨床醫生和供應商的價值。自動化不再是可有可無的附加功能，而是許多高通量環境中的核心支柱。真空技術與自動化採血系統的整合，降低了操作的變異性，並提高了處理能力。除了這些技術變革之外，我們還觀察到材料替代的趨勢。在許多應用情境中，具有生物相容性和抗破損性的塑膠正在取代傳統的玻璃；而聚對苯二甲酸乙二醇酯（PET）和聚丙烯等特殊聚合物，由於其在性能和成本之間的平衡，在一次性產品中的需求也日益成長。

對 2025 年關稅調整如何影響靜脈血液供應鏈的採購趨勢、庫存策略和本地生產應對措施進行分析評估。

美國2025年實施的新關稅措施，對靜脈採血產品的採購和生產成本計算造成了顯著影響。進口零件和成品的關稅增加了某些原料和組件的到貨成本，迫使採購團隊重新評估籌資策略和總擁有成本（TCO）。為此，一些製造商正在加快近岸外包的步伐，或調整其全球生產佈局，以減輕額外關稅的影響。同時，有些製造商則選擇短期內承擔這些成本，以維持合約價格和客戶關係。

將產品變體、技術、材料、臨床應用和最終用戶與可操作的商業化策略聯繫起來的詳細細分分析。

深入了解市場區隔對於確定產品開發優先順序、銷售策略和臨床應用路徑至關重要。從產品層面來看，此類別涵蓋了從血袋和靜脈輸液導管到最先進的微流體系統等各種產品。在採血管路中，還存在更細分的類別，包括EDTA管路、肝素管路、微型容器和微型血細胞比容管路、血漿分離管路、血清分離管路以及真空採血管路，每種管路都針對不同的分析流程和分析前穩定性要求。技術分類則區分了與實驗室設備整合的自動化採血系統和強調標準化血液量和檢體完整性的真空採血技術。這些方法的選擇通常取決於實驗室的容量和人員配備需求。

從全面的區域觀點揭示監管多樣性、臨床實踐和供應鏈物流如何影響全球的採用和商業化。

區域趨勢對監管路徑、報銷機制、供應鏈設計以及技術採納速度有顯著影響。在美洲，採購往往傾向於那些能夠證明符合國家標準並提供在地化物流和技術支援的供應商。另一方面，臨床需求通常集中在大都會圈優先考慮自動化以管理處理能力。歐洲和中東及非洲（EMEA）地區擁有不同的管理體制和醫療服務模式，成本控制和醫療設備生命週期管理是許多市場的關鍵考量。在這些地區，與實驗室資訊系統的互通性以及對區域醫療設備指令的遵守對於市場准入和永續應用至關重要。在亞太地區，一些都市化市場正經歷著快速的採納曲線，這得益於對公共衛生的投資、不斷擴展的診斷網路以及能夠滿足區域和全球需求的強大的國內製造業基礎。

以技術差異化、供應可靠性和策略夥伴關係關係為重點，對長期市場領導地位的決定因素進行詳細的競爭分析。

靜脈採血領域的競爭格局由產品創新、通路策略和卓越營運三者共同塑造。主要企業透過結合專有技術、高標準的生產製造以及與醫療機構的策略合作，在真實的臨床環境中檢驗產品性能，從而脫穎而出。一些企業專注於自動化和設備/耗材生態系統，以創造持續的收入來源並鞏固長期合約。而有些企業則強調提供種類齊全的一次性產品和成本領先優勢，以贏得預算有限但用量大的客戶。良好的品管系統和合規記錄仍然是重要的競爭優勢，那些能夠證明其產品檢驗能力強、即使在市場動盪時期也能保持穩定供應的企業，往往能夠鞏固其作為首選供應商的地位。

為製造商和相關人員提供可操作的策略重點，以增強產品適應性、供應韌性和基於證據的商業性差異化。

尋求競爭優勢的領導企業應採取多管齊下的策略，將產品開發、供應鏈策略和客戶參與有機結合。他們應優先考慮模組化產品架構，使核心平台能夠適應特定的臨床應用，從而加快客製化解決方案的上市速度，同時保持生產效率。同時，他們應加強供應商多元化，並考慮對關鍵零件採取策略性近岸外包或雙源採購安排，以降低貿易政策波動和物流中斷帶來的風險。在商業方面，他們應提供儀器和耗材的捆綁銷售，並提供以結果為導向的服務契約，將重點從單一銷售額轉移到可衡量的臨床和營運效益。

為了支持實際見解，我們採用透明的混合方法研究途徑，將一手訪談、第二手資料和檢驗結合。

本研究採用混合方法，旨在確保透明度和可重複性，同時整合定性和定量資訊。主要研究包括對臨床醫生、採購經理和製造企業高管進行結構化訪談，以了解實際優先事項、實施障礙和營運限制。次要研究整合了公開的監管文件、標準文件和同行評審文獻，以檢驗產品規格和材料考慮。採用資料檢驗來協調不同的訊息，從而提高主題結論和策略意義的可靠性。

本文概述了創新、法規和採購趨勢如何交織，並將決定靜脈血採樣領域未來的競爭優勢。

總而言之，靜脈採血正處於一個轉折點，其驅動力來自於技術進步、材料創新以及受貿易和監管壓力影響的商業性趨勢轉變。相關人員應預見到，自動化、安全設計以及兼顧性能和可製造性的材料將繼續受到關注。關稅趨勢正在加速對製造地和籌資策略的策略性重新評估，這可能會造成短期混亂，但也為靈活的供應商提供了透過提供在地化生產和可靠物流來贏得市場佔有率的機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：靜脈採血市場：依產品類型分類

  • 採血袋
  • 採血管
    • EDTA管
    • 肝素管
    • 微型容器管
    • 微量血球容積比管
    • 血漿分離管
    • 血清分離管
    • 真空採血管
  • 《採血針》
  • 微流體系統
  • 針頭/注射器
  • 靜脈插管
  • 加溫裝置

第9章：靜脈採血市場：依技術分類

  • 自動化採血系統
  • 真空採血技術

第10章：靜脈血液採集市場：依材料類型分類

  • 陶瓷製品
  • 玻璃
  • 塑膠
    • 聚對苯二甲酸乙二酯
    • 聚丙烯
  • 不銹鋼

第11章：靜脈血液採集市場：依應用領域分類

  • 術中採血
  • 靜脈血氣分析
  • 靜脈穿刺

第12章：靜脈血液採集市場：依最終用戶分類

  • 捐血中心
  • 診斷中心
  • 醫院和診所

第13章：靜脈採血市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：靜脈採血市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：靜脈採血市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國靜脈血液採集市場

第17章：中國靜脈採血市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AdvaCare International
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biosigma SpA
  • Cardinal Health, Inc.
  • Demophorius Limited
  • ELITech Group by Bruker Corporation
  • FL MEDICAL srl
  • Fresenius Kabi AG
  • Greiner Bio-One International GmbH
  • Medtronic PLC
  • Narang Medical Ltd.
  • Nipro Europe Group Companies
  • Plymouth Tube Company LLC
  • Poly Medicure Limited
  • PTS Diagnostics by Sinocare
  • QIAGEN GmbH
  • SARSTEDT AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Zhejiang Gongdong Medical Technology Co., Ltd.
Product Code: MRR-742BD5184EB1

The Venous Blood Collection Market was valued at USD 4.90 billion in 2025 and is projected to grow to USD 5.14 billion in 2026, with a CAGR of 5.10%, reaching USD 6.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.90 billion
Estimated Year [2026] USD 5.14 billion
Forecast Year [2032] USD 6.95 billion
CAGR (%) 5.10%

Concise contextual framing of venous blood collection developments linking device innovations, clinical workflows, and procurement priorities for stakeholders

The venous blood collection domain is a foundational element of modern healthcare diagnostics and transfusion medicine, underpinning clinical decision-making across emergency care, routine testing, and complex surgical procedures. Advances in device design, materials science, and automated systems have shifted both operational workflows and supplier value propositions, prompting stakeholders to reassess procurement strategies and clinical protocols. This introduction sets the context for a structured exploration of technology, material innovation, regulatory pressures, and end-user requirements that together shape the competitive landscape.

Over recent years, hospitals, diagnostic centers, and blood donation facilities have placed increasing emphasis on safety, traceability, and throughput. Innovations such as vacuum collection technologies, microfluidic systems, and enhanced single-use consumables have been adopted to reduce pre-analytical errors, improve sample integrity, and streamline staff training. Concurrently, manufacturers are responding with a blend of incremental product refinements and strategic investments in automation to reduce variability and increase capacity. This section frames the subsequent analysis by identifying the core drivers that influence purchasing decisions, clinical adoption, and supplier differentiation, preparing readers to interpret deeper insights on segmentation, regional dynamics, and trade impacts.

Clear exposition of how technological advances, material innovation, regulatory focus, and supply chain resilience are reshaping the venous collection ecosystem

The landscape of venous blood collection is being transformed by a confluence of technological, regulatory, and operational shifts that are redefining value for clinicians and suppliers alike. Automation is no longer a peripheral enhancement but a central pillar in many high-volume settings, where automated collection systems and integrated vacuum technologies reduce variability and support higher throughput. These technology shifts are paralleled by material substitution trends; plastics engineered for biocompatibility and reduced breakage are displacing traditional glass in many use cases, while specialty polymers such as polyethylene terephthalate and polypropylene are increasingly specified for disposables to balance performance and cost.

Regulatory scrutiny has intensified around safety-engineered devices and traceability, pushing manufacturers to invest in design-for-safety and to provide robust documentation for sterilization and biocompatibility. Simultaneously, supply chain resilience has become a strategic imperative, driving diversification of suppliers and a reevaluation of single-source dependencies. Clinicians are demanding solutions that minimize pre-analytical variability-particularly for sensitive applications like vein blood gas sampling and intraoperative blood salvage-further accelerating adoption of microfluidic systems and standardized collection tubes. Taken together, these shifts are catalyzing product consolidation, greater emphasis on interoperability with laboratory information systems, and new commercial models that bundle consumables with automated instrumentation to lock in recurring revenue and reduce end-user friction.

Analytical assessment of how 2025 tariff adjustments have catalyzed sourcing shifts, inventory strategies, and localized manufacturing responses in venous collection supply chains

The implementation of new tariff measures in the United States during 2025 has introduced measurable friction into the procurement and manufacturing calculus for venous blood collection products. Tariffs on imported components and finished devices have increased landed costs for certain materials and subassemblies, prompting procurement teams to reexamine sourcing strategies and total cost of ownership. In response, some manufacturers have accelerated nearshoring initiatives or adjusted global production footprints to mitigate exposure to additional duties, while others have absorbed costs in the short term to preserve contractual pricing and maintain customer relationships.

Beyond direct price impacts, tariffs have influenced inventory policies and lead-time planning. Organizations facing higher import duties have moved toward larger safety stocks or dual-sourcing arrangements, creating temporary demand surges for readily available product lines and pressuring logistics networks. For suppliers, the tariffs have elevated the importance of localized regulatory compliance, as shifting production sites encounter different registration requirements and quality audit regimes. The cumulative effect has been a reorientation of supplier selection criteria toward partners with diversified manufacturing footprints and demonstrated agility in tariff-affected trade lanes. This dynamic has also spurred strategic conversations around vertical integration and contract manufacturing to control cost drivers that are sensitive to trade policy changes.

In-depth segmentation analysis linking product variants, technologies, materials, clinical applications, and end users to practical commercialization strategies

Understanding granular segmentation is essential to prioritize product development, sales strategies, and clinical adoption pathways. Product-wise, the category covers a spectrum from blood bags and venous cannula to pruning-edge microfluidic systems; within blood collection tubes, there exists a further differentiation across anticoagulant-specific EDTA tubes, heparin tubes, microcontainer and microhematocrit tubes, plasma separation tubes, serum separating tubes, and vacuum blood collection tubes, each addressing distinct analytical workflows and pre-analytical stability requirements. Technology segmentation distinguishes between automated collection systems that integrate with laboratory instrumentation and vacuum collection technology that focuses on standardized draw volume and sample integrity; the choice between these approaches often depends on facility throughput and staff availability.

Material selection drives performance, cost and regulatory pathways, with ceramic and stainless steel components retained in reusable or specialized applications while glass and an expanding range of plastics, including polyethylene terephthalate and polypropylene, dominate disposables due to lower breakage risk and manufacturability. Application-specific needs such as intraoperative blood salvage, vein blood gas sampling, and routine venipuncture impose varying demands on device sterility, sample preservation, and ergonomic design, influencing the optimal configuration of consumables and instruments. End users-spanning blood donation centers, diagnostic centers, and hospitals and clinics-prioritize different value propositions: donation centers emphasize donor comfort and throughput, diagnostic centers prioritize sample traceability and standardization, and hospitals require versatility across acute and elective care. Mapping these segmentation dimensions against clinical use cases yields actionable differentiation strategies for product managers and commercial teams seeking to align specifications with buyer priorities.

Comprehensive regional perspective revealing how regulatory diversity, clinical practices, and supply chain logistics shape adoption and commercialization globally

Regional dynamics exert a profound influence on regulatory pathways, reimbursement mechanisms, supply chain design, and the pace of technology adoption. In the Americas, procurement tends to favor suppliers that demonstrate regulatory compliance with domestic standards and the ability to provide localized logistics and technical support, while clinical demand often concentrates in high-volume urban centers that prioritize automation to manage throughput. Europe, the Middle East & Africa presents a mosaic of regulatory regimes and healthcare delivery models, with an emphasis in many markets on cost containment and device lifecycle management; here, interoperability with laboratory information systems and compliance with regional device directives are salient for market entry and sustained adoption. Asia-Pacific showcases rapid adoption curves in several urbanized markets, driven by public health investment, expanding diagnostic networks, and a strong domestic manufacturing base that supplies both regional and global demand.

Across all regions, differences in clinical practice patterns-such as preferences for specific tube types or single-use versus reusable devices-translate into varied product mixes and commercial approaches. Tariff environments, trade agreements, and transportation infrastructure further influence distribution models and inventory strategies. For companies seeking to scale globally, regional insights inform decisions on where to locate manufacturing, how to sequence regulatory filings, and which partner ecosystems to build for sales, service, and supply chain resiliency. Effective regional strategies therefore combine an understanding of clinical workflows with pragmatic assessments of regulatory timelines and logistics capabilities.

Detailed competitive analysis emphasizing technology differentiation, supply reliability, and strategic partnerships as determinants of long-term market leadership

Competitive dynamics in venous blood collection are driven by a mix of product innovation, channel strategy, and operational excellence. Leading organizations differentiate through a combination of proprietary technologies, high-quality manufacturing standards, and strategic partnerships with clinical institutions to validate performance in real-world settings. Some firms concentrate on automation and instrument-consumable ecosystems to create recurring revenue streams and lock in long-term contracts, while others emphasize breadth of disposables and cost leadership to capture high-volume accounts with tight budgetary constraints. Quality systems and regulatory track records remain critical competitive levers; companies that can demonstrate robust product validation and consistent supply during periods of disruption tend to secure preferred-supplier status.

Mergers and partnerships continue to be a feature of the sector as firms seek to complement capabilities-pairing advanced materials expertise with distribution networks, for example-or to expand geographically without incurring the full cost of greenfield manufacturing. Investment in R&D is concentrated on improving sample stability, reducing hemolysis rates, enhancing patient comfort during collection, and integrating data capture for traceability. Service models that include training, maintenance, and bundled consumable procurement are increasingly attractive to hospital systems aiming to reduce administrative complexity. In this environment, commercial success depends on the ability to demonstrate clinical value, control total cost of ownership, and offer resilient supply arrangements that accommodate regional regulatory nuances.

Actionable strategic priorities for manufacturers and stakeholders to strengthen product adaptability, supply resilience, and evidence-based commercial differentiation

Leaders seeking to capture advantage should pursue a multifaceted approach that aligns product development, supply chain strategy, and customer engagement. Prioritize modular product architectures that allow adaptation of core platforms to specific clinical applications, thereby reducing time-to-market for tailored solutions while preserving manufacturing efficiency. In parallel, strengthen supplier diversification and consider strategic nearshoring or dual-source arrangements for critical components to limit exposure to trade policy volatility and logistics disruptions. Commercially, bundle instrumentation with consumables and offer outcome-oriented service agreements that shift focus from unit sales to measurable clinical and operational benefits.

Operational excellence must be complemented by intentional regulatory planning: invest in global regulatory intelligence to optimize filings and reduce time-to-adoption across regions. Enhance value propositions by partnering with clinical leaders to generate real-world evidence that quantifies improvements in sample quality, processing times, or patient experience. Finally, deploy customer education programs that address procedural best practices for venipuncture and specimen handling, thereby lowering pre-analytical variability and increasing the perceived value of premium consumables. These actions, taken together, position organizations to be responsive to clinician needs while maintaining cost discipline and supply resilience.

Transparent blended-methods research approach integrating primary interviews, secondary documentation, and triangulation to underpin actionable findings

The research foundation is built on a blended-methods approach designed to synthesize qualitative and quantitative inputs while ensuring transparency and reproducibility. Primary research included structured interviews with clinicians, procurement leaders, and manufacturing executives to capture real-world priorities, adoption barriers, and operational constraints. Secondary research integrated publicly available regulatory filings, standards documentation, and peer-reviewed literature to validate product specifications and material considerations. Data triangulation techniques were applied to reconcile differing inputs, enhancing confidence in thematic conclusions and strategic implications.

Analytical steps involved categorizing products and technologies against defined segmentation dimensions-product type, technology, material type, application, and end user-and mapping regional regulatory and logistical variables to commercial models. Sensitivity checks focused on supply chain disruption scenarios and tariff-induced cost pressures to evaluate supplier responses and buyer adaptations. Where possible, anonymized case studies and illustrative examples were used to ground insights in practice. Methodological limitations are acknowledged, including the evolving nature of trade policy and the lag between product development cycles and published clinical evidence; nonetheless, the approach emphasizes triangulation and stakeholder validation to produce actionable conclusions for decision-makers.

Concluding synthesis emphasizing how innovation, regulation, and sourcing dynamics converge to define future competitive advantage in venous collection

In sum, venous blood collection is at an inflection point driven by technology adoption, material innovation, and shifting commercial dynamics influenced by trade and regulatory pressures. Stakeholders should expect continued emphasis on automation, safety-engineered designs, and materials that balance performance with manufacturability. Tariff developments have accelerated strategic reconsideration of manufacturing footprints and sourcing strategies, creating near-term disruption but also opportunities for agile suppliers to capture share by offering localized production and reliable logistics.

For healthcare providers and diagnostic operators, aligning procurement decisions with clinical priorities-minimizing pre-analytical variability, ensuring sample integrity for specific assays, and optimizing staff workflows-will remain paramount. For manufacturers and investors, success will come from integrating robust quality systems, pursuing partnerships that validate clinical value, and deploying flexible commercial models that can adapt to regional regulatory and economic conditions. The collective trajectory suggests a more resilient, innovation-driven market that rewards technical excellence, supply reliability, and evidence-based value propositions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Venous Blood Collection Market, by Product Type

  • 8.1. Blood Bags
  • 8.2. Blood Collection Tube
    • 8.2.1. EDTA Tube
    • 8.2.2. Heparin Tube
    • 8.2.3. Microcontainer Tubes
    • 8.2.4. Microhematocrit Tubes
    • 8.2.5. Plasma Separation Tube
    • 8.2.6. Serum Separating Tube
    • 8.2.7. Vacuum Blood Collection Tubes
  • 8.3. Lancets
  • 8.4. Microfluidic System
  • 8.5. Needles & Syringes
  • 8.6. Venous Cannula
  • 8.7. Warming Devices

9. Venous Blood Collection Market, by Technology

  • 9.1. Automated Collection Systems
  • 9.2. Vacuum Collection Technology

10. Venous Blood Collection Market, by Material Type

  • 10.1. Ceramic
  • 10.2. Glass
  • 10.3. Plastic
    • 10.3.1. Polyethylene Terephthalate
    • 10.3.2. Polypropylene
  • 10.4. Stainless Steel

11. Venous Blood Collection Market, by Application

  • 11.1. Intraoperative Blood Salvage
  • 11.2. Vein Blood Gas Sampling
  • 11.3. Venipuncture

12. Venous Blood Collection Market, by End User

  • 12.1. Blood Donation Centers
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals & Clinics

13. Venous Blood Collection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Venous Blood Collection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Venous Blood Collection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Venous Blood Collection Market

17. China Venous Blood Collection Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AdvaCare International
  • 18.7. Baxter International Inc.
  • 18.8. Becton Dickinson and Company
  • 18.9. Bio-Rad Laboratories, Inc.
  • 18.10. Biosigma S.p.A.
  • 18.11. Cardinal Health, Inc.
  • 18.12. Demophorius Limited
  • 18.13. ELITech Group by Bruker Corporation
  • 18.14. FL MEDICAL s.r.l.
  • 18.15. Fresenius Kabi AG
  • 18.16. Greiner Bio-One International GmbH
  • 18.17. Medtronic PLC
  • 18.18. Narang Medical Ltd.
  • 18.19. Nipro Europe Group Companies
  • 18.20. Plymouth Tube Company LLC
  • 18.21. Poly Medicure Limited
  • 18.22. PTS Diagnostics by Sinocare
  • 18.23. QIAGEN GmbH
  • 18.24. SARSTEDT AG & Co. KG
  • 18.25. Sekisui Medical Co., Ltd.
  • 18.26. Terumo Corporation
  • 18.27. Thermo Fisher Scientific Inc.
  • 18.28. Zhejiang Gongdong Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VENOUS BLOOD COLLECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VENOUS BLOOD COLLECTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY EDTA TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY EDTA TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY EDTA TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY HEPARIN TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY HEPARIN TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY HEPARIN TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROCONTAINER TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROCONTAINER TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROCONTAINER TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROHEMATOCRIT TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROHEMATOCRIT TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROHEMATOCRIT TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASMA SEPARATION TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASMA SEPARATION TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASMA SEPARATION TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY SERUM SEPARATING TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY SERUM SEPARATING TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY SERUM SEPARATING TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VACUUM BLOOD COLLECTION TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VACUUM BLOOD COLLECTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VACUUM BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY LANCETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY LANCETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY LANCETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROFLUIDIC SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROFLUIDIC SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MICROFLUIDIC SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY NEEDLES & SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY NEEDLES & SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY NEEDLES & SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VENOUS CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VENOUS CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VENOUS CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY WARMING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY WARMING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY WARMING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY AUTOMATED COLLECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY AUTOMATED COLLECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY AUTOMATED COLLECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VACUUM COLLECTION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VACUUM COLLECTION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VACUUM COLLECTION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY INTRAOPERATIVE BLOOD SALVAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY INTRAOPERATIVE BLOOD SALVAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY INTRAOPERATIVE BLOOD SALVAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VEIN BLOOD GAS SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VEIN BLOOD GAS SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VEIN BLOOD GAS SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VENIPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VENIPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY VENIPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD DONATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD DONATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD DONATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 173. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 197. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. G7 VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 202. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 205. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL VENOUS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY BLOOD COLLECTION TUBE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA VENOUS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)